NL-OMON23000招募中不适用
DNA damage response in tumours of patients with endometrial cancer
ErasmusMC0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with all subtypes of endometrial cancer
排除标准
- •Patients will be informed upfront that any relevant findings in this study will be reported back to themselves and to their attending physicians. They cannot participate in the study when they do not consent to these criteria.
研究者
相似试验
尚未招募
不适用
A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage.CTRI/2010/091/000015Dr. KH Reeta,Assistant professorDepartment of PharmacologyAIIMS, New Delhi-11002930
已完成
不适用
Study of the anti-tumor effects by oligonucleotides among the patients with primary lung cancerung cancerJPRN-UMIN000017816Yokohama City University30
进行中（未招募）
不适用
Vitamin C as an anti-cancer drugEUCTR2008-008692-33-DKDepartment of Urology, Herlev Hospital
招募中
不适用
DNA damage and Nutritional Profile of ApoE4 carriers, the Major Genetic Risk Factor for Alzheimer’s DiseaseNeurological - Alzheimer's diseaseAlzheimer's DiseaseACTRN12612000098831Commonwealth Scientific and Industrial Research Organisation200
招募中
不适用
Assessment of DNA damage-repair capacity in systemic lupus erythematosus patients as a potential biomarker of response to cyclophosphamide.Lupus nephritisACTRN12620001287921niversity of Auckland17